ROCKET PHARMACEUTICALS, INC. - 8-K Filing
Rocket Pharmaceuticals held its 2026 Annual Meeting of Stockholders on May 20, 2026. Shareholders approved the election of seven directors with votes ranging from 43 million to 62 million in favor; ratified EisnerAmper LLP as their independent registered accounting firm (79 million for); approved executive compensation advisory vote (61 million for); and approved a stock option exchange program (45 million for). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $RCKT